We were neither able to find differences in levels of serum ACSL4 or AIFM2 between patients and controls, nor were we able to identify significant associations between clinical disease and these two molecules previously linked to ferroptosis in preclinical models of COPD. The gene discussed is AIFM2; the disease is chronic obstructive pulmonary disease.